Nina Horowitz, PhD

CEO
ImmuneBridge
San Francisco, CA

Nina Horowitz, PhD, is a bioengineer and scientific leader committed to advancing immunotherapies that can cure cancer and other serious diseases. She currently serves as Chief Executive Officer at ImmuneBridge, where she is driving the development of next-generation cell therapies with a focus on safety, accessibility, and broad clinical impact. Nina joined ImmuneBridge in 2022, initially leading NK cell therapy research before stepping into the CSO and then CEO role. Her work integrates insights from bioengineering, immunology, synthetic biology, and AI to translate cutting-edge science into clinical solutions. She earned her PhD and MS in Bioengineering from Stanford University.

Presentation(s):

• Featured Topic: From Code to Care: AI’s Promise & Pitfalls in Medicine

  Monday, October 6, 2025
  12:30 PM - 5:00 PM US EDT

• AI/ML Ethical, Legal, Social Implications and Pitfalls

  Monday, October 6, 2025
  3:50 PM - 4:50 PM US EDT